New Report Uncovers Big Pharma’s Abuses Cost U.S. Health Care System $31.7 Billion

Roundtable Joins the Coalition for Affordable Prescription Drugs in Release of New Report

Today, the Coalition for Affordable Prescription Drugs (CAPD) released a new report from Matrix Global Advisors, “Gamesmanship and Other Barriers to Drug Competition.” The report shows how brand drug companies have used anticompetitive tactics to delay the entry of generic competition and sustain monopolies. According to the report, stopping this gamesmanship could save U.S. patients and taxpayers over $30 billion.

“Millions of public sector employees, retirees, and their dependents rely on prescription drugs every day to cure and manage their health conditions, and the members of the Public Sector HealthCare Roundtable work diligently to ensure timely access to these medications at a cost that is reasonable,” said Gary Harbin, CPA, Executive Secretary of the Teachers’ Retirement System of Kentucky and Chairman of the Board, Public Sector HealthCare Roundtable. “Unfortunately, the skyrocketing list prices of drugs in this country – and particularly specialty drugs – creates enormous barriers to achieving these goals. This report offers critically important, market-based solutions to address the crisis of rising drug prices not just for public sector workers, retirees, and their families but for all Americans.”  

Read Brill Report Release
Read Full Report – “Gamesmanship and Other Barriers to Drug Competition.”